Reuters logo
5 个月前
BRIEF-Aethlon Medical announces the conclusion of hemopurifier clinical study
2017年3月13日 / 中午11点44分 / 5 个月前

BRIEF-Aethlon Medical announces the conclusion of hemopurifier clinical study

March 13 (Reuters) - Aethlon Medical Inc

* Aethlon Medical announces the conclusion of hemopurifier clinical study

* Aethlon Medical - in feasibility study, hemopurifier observed to be well tolerated in ESRD volunteers who were also infected with hepatitis c virus

* Aethlon Medical Inc says no device-related adverse events were observed in enrolled subjects who met study inclusion/exclusion criteria

* Aethlon Medical Inc - company also seeks to advance hemopurifier under provisions of 21st century cures act, which was signed into law in Dec 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below